MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis
Conclusion: We identified a distinct circulatory miRNA profile in pediatric CFLD with potential to accurately discriminate liver disease and fibrosis severity in children with CF.
Source: Hepatology - Category: Internal Medicine Authors: Diego A. Calvopina,
Mark D. Chatfield,
Anna Weis,
Miranda A. Coleman,
Manuel A. Fernandez ‐Rojo,
Charlton Noble,
Louise E. Ramm,
Daniel H. Leung,
Peter J. Lewindon,
Grant A. Ramm Tags: Original Article Source Type: research
More News: Children | Cystic Fibrosis | Grants | Internal Medicine | Liver | Liver Disease | Pediatrics | Study | Urology & Nephrology